Navigation Links
New Findings on Autism Research

Researches have found that different genes may be involved in causing autism in boys and girls. They have also noted that other genes may also be involved //in the early- and late-onset form of the developmental disorder in a new study published in the online edition of the journal Molecular Genetics.

The study also provides new evidence for the idea that multiple genes contribute to autism, said lead author Gerard Schellenberg, a researcher at the Puget Sound Veterans Affairs Medical Center and a research professor of medicine at the University of Washington. The research team was headed by Schellenberg, Ellen Wijsman, a UW research professor of medical genetics and Geraldine Dawson, director of the UW's Autism Center.

"It is highly unlikely that there is only one gene responsible for autism," said Schellenberg. "There may be four to six major genes and 20 to 30 others that might contribute to autism to a lesser degree.

"If an individual only gets three high-risk variants of these genes, it could mean a less-severe form of autism. And because autism is rarer in females, it may take more risk genes for a female to have autism. There also is the possibility that there might be a biological difference in autism for females versus males," he said.

"What is meaningful is that we have found evidence for two genetic subtypes of autism, male versus female and early versus late onset," added Geraldine Dawson, a professor of psychology. "This is a critical piece of information. With Alzheimer's disease research, one big breakthrough was segregating the late and early onset forms of the disease, and this led to important genetic discoveries."

Schellenberg said the study came up with "strong support" for an autism gene on chromosome 7 and "less, but still compelling evidence" for genes on chromosomes 3, 4 and 11. These results confirm some data from previous studies, particularly involving chromosome 7.

T
'"/>




Page: 1 2

Related medicine news :

1. Latest Findings On The Deadly Disease - SARS
2. New Findings Could Reduce The Extent Of Spinal Cord Injuries
3. New Findings for Repeated Miscarriages
4. How Healthy Are Herbal Products? US Findings.
5. Dispute in Findings about Radiation exposure
6. Engineering Nutrient-Rich Plants Made For Feasible By New Findings
7. Study Findings Could Help In Developing A Better Drug Delivery System
8. Findings Suggest New Method to Fight Staph Infections
9. Most Suicide Rates Decline, but Findings Are Puzzling
10. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
11. Soy Protein Study Generates New Findings
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Findings Autism Research

(Date:5/11/2008)...ounter and safely used at home , , SUNDA...ur spring cleaning, don,t forget your nose. , N... with spring allergies, nasal congestion, stuffy n...elissa Pynnonen, co-director of the Michigan Sinus...ty of Michigan,s department of otolaryngology. ,...
(Date:5/10/2008)... -- The American Refugee Committee,(ARC) is delive...dy in,Myanmar. In partnership with World Vision, A...ood, including items such as water purification,ta...f survivors., ARC will also send a relief team to...l be led by ARC Thailand Country Director Gary Dah...
(Date:5/9/2008)...e-FirstCall/ -- AMDL, Inc. (Amex: ADL ),an inter...tical company,with operations in China through its..., today announced that its consolidated financial,...hich were included in its,Annual Report on Form 10...on on April 14, 2008, contained a ,going concern, ...
(Date:5/9/2008)...r Maintenance Treatment for ADHD, INDIANAPOLIS, M...ny,(NYSE: LLY ) announced today that the United S...ved Strattera(R) (atomoxetine HCI) for,maintenance...rder (ADHD) in,children and adolescents. Strattera...s the first FDA-approved non-stimulant to treat AD...
Breaking Medicine News(10 mins):Health News:Nasal Irrigation Can Help Fight Spring Allergies 2Health News:AMDL Reports Going Concern Qualification 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6
...the US and India received the Prince Mahidol Award...for their contribution// to medical and public hea...or their achievements in the discovery, introducti...al re-hydration solution (ORS) or oral re-hydratio...
...ssion confirmed Monday the first outbreak of the H... tests on Hungarian geese proved positive//. But e...ing. European Health Commissioner Markos Kypriano...their vigilance" and to reassess their risk levels...
...ington University School of Medicine in St. Louis ...uccessfully tested a technique for identifying// n...disease risk. Rather than focus on errors and al...ique highlights variations in the number of copies...
...iew of the latest clinical trials, coronary artery...out the aid of a heart-lung machine//, is a safe o...r bypass patients. This review is featured in Jour...t was more common for doctors to perform artery by...
Other Medicine News:Health News:US, Indian Doctors Bag Thai Medical Awards 2Health News:Effects of Multiple Copies of Genes on Disease Risk 2
(Date:5/9/2008)...wire/ -- Many strong acting pain,medications have ...and,vomiting with short-term use, and constipation...patients to discontinue treatment, adding addition.... The novel investigational,medication tapentadol,...relief for patients with fewer gastrointestinal si...
(Date:5/9/2008)...hows Positive Results with X-ray ...swire/ -- Roche today announced one-year,results f...TEMRA(TM),(tocilizumab) can significantly inhibit ...ents with rheumatoid arthritis (RA), a critical me...dy also demonstrated that ACTEMRA,reduces disease ...
(Date:5/8/2008)...ement in ADHD symptoms in adults, WASHINGTON, May...Nasdaq: SHPGY), the global specialty biopharmaceut...se III pivotal study in which VYVANSE,demonstrated...eractivity,Disorder (ADHD) symptoms in adults and ...ith ADHD often find it challenging to focus and or...
(Date:5/8/2008)...irstCall/ -- VION PHARMACEUTICALS,INC. (Nasdaq: ...r-sponsored,Phase I/II clinical trial of its lead ...bination with cytarabine in elderly patients with,...ML) and high-risk,myelodysplastic syndromes (MDS)....of Ellen K. Ritchie, M.D. at The Weill-Cornell Med...
Breaking Medicine Technology:New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3Scientists discover a new player in innate immune response 1921 1Scientists discover a new player in innate immune response 1921 2Gastric cancer survivors should be aware of osteoporosis 9613 1Indian medicinal plant Acanthus ilicifolius may combat liver cancer 9611 1Indian medicinal plant Acanthus ilicifolius may combat liver cancer 9611 2A promising new approach to cadmium induced hepatoxicity 3A Cytoprotective effect of midkine 9609 1
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: